Abstract:Triclabendazole is an effective medication to treat fascioliasis and paragonimiasis parasitic infections. We implemented a reliable quantum mechanical method which is density functional theory at the level of ωB97XD/6-31G* along with embedded fragments to elucidate stability and phase transition between two forms of triclabendazole. We calculated crystal structure parameters, volumes, Gibbs free energies, and vibrational spectra of two polymorphic forms of triclabendazole under different pressures and temperatures. We confirmed form I was more stable than form II at atmospheric pressure and room temperature. From high-pressure Gibbs free energy computations, we found a pressure-induced phase transformation between form I (triclinic unit cell) and form II (monoclinic unit cell). The phase transition between forms I and II was found at a pressure and temperature of 5.5 GPa and ≈350 K, respectively. In addition, we also studied the high-pressure polymorphic behavior of two forms of triclabendazole. At the pressure of 5.5 GPa and temperature from ≈350 K to 500 K, form II was more stable than form I. However, at temperatures lower than ≈350 K, form I was more stable than form II. We also studied the effects of pressures on volumes and Raman spectra. To the best of our knowledge, no such research has been conducted to determine the presence of phase transformation between two forms of triclabendazole. This is a case study that can be applied to various polymorphic crystals to study their structures, stabilities, spectra, and phase transformations. This research can assist scientists, chemists, and pharmacologists in selecting the desired polymorph and better drug design.

Three Solid Forms of Chlorantraniliprole: Structure, Characterization, and Phase Transformation

Polymorphic Development Strategy for Rapid Pesticide Release: A Case Study of Spirotetramat

Study on Structure, Stability, and Phase Transformation of Dufulin Polymorphs

Design, Synthesis, and Insecticidal Evaluation of N-Pyridylpyrazole Amide Derivatives Containing 4,5-Dihydroisoxazole Amide As Potential Ryanodine Receptor Activators.

Synthesis of Chlorantraniliprole

Synthesis and Insecticidal Activity of Novel Anthranilic Diamide Insecticides Containing Indane and Its Analogs

A Solid-Solid Phase Transformation of Triclabendazole at High Pressures

Chitosan-Delivered Chlorantraniliprole for Pest Control: Preparation Optimization, Deposition Behavior, and Application Potential

Synthesis, bioactivities and phloem uptake of dipeptide-chlorantraniliprole derivatives

Novel Amino Acid Ester-Chlorantraniliprole Conjugates: Design, Synthesis, Phloem Accumulation and Bioactivity.

Preparation and Comprehensive Evaluation of the Efficacy and Safety of Chlorantraniliprole Nanosuspension

Crystal structure of Mn-based MOF as a new catalyst for synthesizing novel insecticide tetrachlorantraniliprole

Exploring Solid Form Landscape of Anticancer Drug Dimethylaminomicheliolide Fumarate: Crystal Structures Analysis, Phase Transformation Behavior, and Physicochemical Properties Characterization

Anthranilic Diamides Containing Monofluoroalkene Amide Linkers As Potential Insect RyR Activators: Design, Synthesis, Bio-evaluation, and Computational Study.

Microwave assistant one pot synthesis, crystal structure, antifungal activities and 3D-QSAR of novel 1,2,4-triazolo[4,3-a]pyridines.

Synthesis, Insecticidal Activities and Structure-Activity Relationship Studies of Novel Anthranilic Diamides Containing Pyridylpyrazole-4-carboxamide.

Synthesis, crystal structure, spectroscopic characterization and anti-fungal activity of Ethyl 2-Oxo-2H-chromene-3-carboxylateDerivatives

Diamides Conformationally Restricted with Central Amino Acid: Design, Synthesis, and Biological Activities

Bioactive Conformation Analysis of Anthranilic Diamide Insecticides： DFT-based Potential Energy Surface Scanning and 3D-QSAR Investigations

Novel Meta‐Diamide Derivatives Bearing Triazole: Design, Synthesis and Bioactivity

Design, Synthesis, and Insecticidal Bioactivities Evaluation of Pyrrole- and Dihydropyrrole-Fused Neonicotinoid Analogs Containing Chlorothiazole Ring